CenterWatch, a leading publisher of clinical trials information, announced today that it has launched its next-generation virtual news site, CenterWatch News Online. This dynamic, easy-to-navigate, real-time online service features objective news reports covering timely stories and emerging trends in the global clinical research industry.
HT Series II Solvent Evaporators from Genevac offer leading edge features that provide superior sample protection, flexibility for multiple applications, consistency of results, robust build quality, ease-of-use, rapid high-throughput results and low maintenance.
CenterWatch—a leading publisher of clinical trials information—announced that it has more than quadrupled the size of its Clinical Trials Listing Service™ (CTLS). The service now lists more than 80,000 active clinical trials across a wide range of disease conditions, making it the largest online and dynamic database of global clinical trials involving new drugs and devices regulated by the Food and Drug Administration and the Department of Health and Human Services. The listings are accessible free-of-charge for patients, the public and health care professionals.
CenterWatch, a leading publisher in the clinical trials industry, announced today the release of newly revised and expanded editions of two of its top-selling training resources—The CRA’s Guide to Monitoring Clinical Trials, 3rd Edition, and The CRC’s Guide to Coordinating Clinical Trials, 2nd Edition.
Exposure to extreme temperatures in transit can reduce the efficacy of pharmaceutical products. Niclas Ohlsson, TSS AB, explains to Rod James how a company-wide approach to temperature monitoring can result in greater efficiency, improved risk management and reduced costs.
Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, in a white paper released today, concludes that "State and Federal Sunshine Acts Shift KOL Marketing Tactics" by helping to identify and prosecute abusive and/or illegal remuneration that firms and academic institutions have practiced in return for product endorsements by Key Opinion Leader (KOL) physicians -- without sufficient regard for their relative product safety, clinical efficacy and cost.
Malvern, Sturtevant and Schenck joint development offers unprecedented control of micronization processes, for optimal manufacturing efficiency.
Prof. Dr. Wiltrud Treffenfeldt, Global Director for Bioprocess R&D at Dow AgroSciences in Indianapolis, USA was elected to the supervisory board at DASGIP AG. She replaces Dr. Helmut Herz who resigned the board effective from May 20th 2011 after 5 years of membership. Both the Chairman Dr. Jürgen Kieschoweit as well as the long-standing member Rolf Geisen have been reelected.
DASGIP strengthens its market position by combining disposable benchtop bioreactors with the DASGIP technology. Thanks to the unique modularity of the DASGIP Parallel Bioreactor System the Mobius CellReady 3L bioreactor can be integrated seamlessly into DASGIP's control system. In this manner, DASGIP combines the familiar powerful process control with the advantages of disposable technology. The CellReady bioreactor is a single-use stirred tank bioreactor for cell culture process development. The disposable bioreactor eliminates the need to clean and autoclave, thus it accelerates preparation and post-processing time.
DASGIP expand the 3rd party integration program and includes Aber Futura biomass sensors. This integration enables online monitoring of the viable cell concentration during the controlled cultivation in DASGIP Parallel Bioreactor systems. With Aber biomass sensors DASGIP integrates a further analytical tool for the advanced and efficient cultivation of bacteria, yeast and animal cells.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.